Profil
Dewey Steadman is currently the Head of Investor Relations at United Therapeutics Corp.
Previously, he worked as the Executive Director of Investor and Media Relations at Akorn, Inc.
Aktive Positionen von Dewey Steadman
| Unternehmen | Position | Beginn |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Dewey Steadman
| Unternehmen | Position | Ende |
|---|---|---|
| AKORN, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
